Mary E. Devens

1.5k total citations
42 papers, 1.0k citations indexed

About

Mary E. Devens is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mary E. Devens has authored 42 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 18 papers in Pathology and Forensic Medicine and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mary E. Devens's work include Colorectal Cancer Screening and Detection (22 papers), Genetic factors in colorectal cancer (16 papers) and Gastric Cancer Management and Outcomes (16 papers). Mary E. Devens is often cited by papers focused on Colorectal Cancer Screening and Detection (22 papers), Genetic factors in colorectal cancer (16 papers) and Gastric Cancer Management and Outcomes (16 papers). Mary E. Devens collaborates with scholars based in United States and Canada. Mary E. Devens's co-authors include David A. Ahlquist, Douglas W. Mahoney, Jonathan J. Harrington, John B. Kisiel, Paul J. Limburg, Thomas C. Smyrk, Tracy C. Yab, William J. Sandborn, Alan R. Zinsmeister and Julie A. Simonson and has published in prestigious journals such as Annals of Internal Medicine, Gastroenterology and Cancer Research.

In The Last Decade

Mary E. Devens

42 papers receiving 999 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary E. Devens United States	13	595	417	365	242	233	42	1.0k
F. P. Rossini Italy	11	509 0.9×	256 0.6×	334 0.9×	67 0.3×	197 0.8×	21	742
Chikara Ogawa Japan	15	164 0.3×	176 0.4×	247 0.7×	181 0.7×	205 0.9×	50	1.2k
Aline Charabaty United States	12	358 0.6×	170 0.4×	88 0.2×	78 0.3×	123 0.5×	27	575
Myriam Chalabi Netherlands	15	695 1.2×	216 0.5×	217 0.6×	102 0.4×	233 1.0×	38	874
Brindusa Truta United States	11	351 0.6×	48 0.1×	358 1.0×	102 0.4×	151 0.6×	30	633
Joseph W.Y. Lau Hong Kong	13	189 0.3×	118 0.3×	66 0.2×	252 1.0×	306 1.3×	31	860
Naruemon Wisedopas Thailand	15	259 0.4×	254 0.6×	64 0.2×	127 0.5×	255 1.1×	51	735
Edwin J. Lai United States	5	1.0k 1.7×	793 1.9×	55 0.2×	83 0.3×	380 1.6×	6	1.2k
Byonggu An Japan	9	210 0.4×	127 0.3×	86 0.2×	434 1.8×	142 0.6×	19	675

Countries citing papers authored by Mary E. Devens

Since Specialization

Citations

This map shows the geographic impact of Mary E. Devens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Devens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Devens more than expected).

Fields of papers citing papers by Mary E. Devens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Devens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Devens. The network helps show where Mary E. Devens may publish in the future.

Co-authorship network of co-authors of Mary E. Devens

This figure shows the co-authorship network connecting the top 25 collaborators of Mary E. Devens. A scholar is included among the top collaborators of Mary E. Devens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary E. Devens. Mary E. Devens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Witzig, Thomas E., William R. Taylor, Douglas W. Mahoney, et al.. (2024). Blood Plasma Methylated DNA Markers in the Detection of Lymphoma: Discovery, Validation, and Clinical Pilot. American Journal of Hematology. 100(2). 218–228. 3 indexed citations

Shah, Paras, William R. Taylor, Douglas W. Mahoney, et al.. (2024). Methylated DNA Markers in Voided Urine for the Identification of Clinically Significant Prostate Cancer. Life. 14(8). 1024–1024. 2 indexed citations

Burger, Kelli N., Douglas W. Mahoney, Mary E. Devens, et al.. (2023). Neoplasia Diagnosis After Multi-target Stool DNA Is Enhanced Among Lowest Baseline Detectors. Digestive Diseases and Sciences. 68(9). 3721–3731. 1 indexed citations

Mahoney, Douglas W., et al.. (2023). Multitarget Stool DNA Testing Has High Positive Predictive Value for Colorectal Neoplasia on the Second Round of Testing. Clinical Gastroenterology and Hepatology. 21(9). 2399–2406. 2 indexed citations

Kahn, Allon, Eduardo A. Rodríguez, Mary E. Devens, et al.. (2019). Su1664 – High Yield of Total and Right-Sided Colorectal Neoplasia by Multi-Target Stool Dna Testing in Average Risk Patients Irrespective of Prior Screening. Gastroenterology. 156(6). S–602. 2 indexed citations

Suh, Yun‐Suhk, Boram Choi, Hyuk‐Joon Lee, et al.. (2018). Detection of Gastric Cancer with Novel Methylated DNA Markers: Discovery, Tissue Validation, and Pilot Testing in Plasma. Clinical Cancer Research. 24(22). 5724–5734. 47 indexed citations

Iyer, Prasad G., William R. Taylor, Michele L. Johnson, et al.. (2018). Highly Discriminant Methylated DNA Markers for the Non-endoscopic Detection of Barrett's Esophagus. The American Journal of Gastroenterology. 113(8). 1156–1166. 43 indexed citations

Cotter, Thomas G., Kelli N. Burger, Mary E. Devens, et al.. (2016). Long-term Follow-up of Patients Having False-Positive Multitarget Stool DNA Tests after Negative Screening Colonoscopy: The LONG-HAUL Cohort Study. Cancer Epidemiology Biomarkers & Prevention. 26(4). 614–621. 24 indexed citations

Johnson, David H., John B. Kisiel, Kelli N. Burger, et al.. (2016). Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening. Gastrointestinal Endoscopy. 85(3). 657–665.e1. 38 indexed citations

10.

Johnson, David, John B. Kisiel, Kelli N. Burger, et al.. (2016). Su1044 Knowledge of a Positive Cologuard™ Result Improves Yield and Quality of Colonoscopy. Gastroenterology. 150(4). S454–S454. 1 indexed citations

11.

Redwood, Diana, Elvin Asay, Frank Sacco, et al.. (2015). Stool DNA Testing for Screening Detection of Colorectal Neoplasia in Alaska Native People. Mayo Clinic Proceedings. 91(1). 61–70. 82 indexed citations

12.

Smyrk, Thomas C., Kari Anderson, Douglas W. Mahoney, et al.. (2015). Endoscopic overestimation of colorectal polyp size. Gastrointestinal Endoscopy. 83(1). 201–208. 73 indexed citations

13.

Giakoumopoulos, Maria, Tracy C. Yab, William R. Taylor, et al.. (2015). Sa1921 Molecular Detection of Colorectal Neoplasia: Do Markers That Target Acquired DNA Alterations in Sporadic Cases Also Discriminate Lynch Syndrome Cases?. Gastroenterology. 148(4). S–355. 1 indexed citations

14.

Lidgard, Graham P., Michael J. Domanico, Janelle J. Bruinsma, et al.. (2013). Clinical Performance of an Automated Stool DNA Assay for Detection of Colorectal Neoplasia. Clinical Gastroenterology and Hepatology. 11(10). 1313–1318. 102 indexed citations

15.

Kisiel, John B., Tracy C. Yab, William R. Taylor, et al.. (2010). 481 Noninvasive Detection of Colorectal Neoplasia (CRN) in Inflammatory Bowel Disease (IBD) by Stool DNA Testing: A Pilot Study. Gastroenterology. 138(5). S–68. 2 indexed citations

16.

Zou, Hongzhi, Xuan Jiang, Jonathan J. Harrington, et al.. (2009). T2037 Quantitative Stool DNA Testing for Detection of Both Colorectal Cancer and Advanced Adenoma. Gastroenterology. 136(5). A–625. 5 indexed citations

17.

Limburg, Paul J., Mary E. Devens, Jonathan J. Harrington, et al.. (2003). Prospective Evaluation of Fecal Calprotectin As A Screening Biomarker for Colorectal Neoplasia. The American Journal of Gastroenterology. 98(10). 2299–2305. 53 indexed citations

18.

Ahlquist, David A., Alan J. Cameron, James R. Jett, et al.. (2000). Universal detection of aerodigestive cancers by assay of nonapoptotic human DNA in stool. Gastroenterology. 118(4). A855–A855. 8 indexed citations

19.

Limburg, Paul J., David A. Ahlquist, William J. Sandborn, et al.. (2000). Fecal Calprotectin Levels Predict Colorectal Inflammation Among Patients With Chronic Diarrhea Referred for Colonoscopy. The American Journal of Gastroenterology. 95(10). 2831–2837. 129 indexed citations

20.

Devens, Mary E., et al.. (1996). The influence of potassium intake on dipper and nondipper blood pressure status in an African-American adolescent population.. PubMed. 1(6). 447–455. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact